NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Non-Surgical Brain Implants for Cancer and Neurological Conditions
TL;DR
MIT's wireless brain implants offer a competitive edge by enabling non-surgical treatment of tumors and neurological conditions, reducing recovery time and healthcare costs.
MIT researchers demonstrated microscopic electronics injected into the bloodstream autonomously navigate to diseased brain tissue and deliver electrical stimulation without surgery.
This technology makes the world better by eliminating invasive brain surgery, reducing patient trauma and improving access to neurological treatments globally.
Tiny wireless devices can self-navigate through the bloodstream to target brain regions, revolutionizing how we treat neurological conditions without surgery.
Found this article helpful?
Share it with your network and spread the knowledge!
These are microscopic wireless electronics that are injected into the bloodstream and can autonomously locate and navigate to diseased brain tissue without human guidance, where they deliver electrical stimulation to treat conditions.
It could eliminate the need for invasive brain surgery when treating tumors and neurological conditions, providing a non-surgical alternative for targeted brain treatment.
Massachusetts Institute of Technology researchers developed the technology and have demonstrated it successfully in mice during clinical studies.
The tiny devices are injected directly into the bloodstream and self-navigate through the circulatory system to reach target regions in the brain autonomously.
The technology is designed to treat brain tumors and various neurological conditions by providing focused, targeted treatment to diseased brain tissue.
The technology is currently going through the clinical study process, having been successfully demonstrated in mice, but human trials are not mentioned in the content.
The content mentions CNS Pharmaceuticals Inc. (NASDAQ: CNSP) as another company making notable progress in this field, though specific details about their technology are not provided.
Investors can access the latest news and updates about CNS Pharmaceuticals Inc. in the company's newsroom at https://ibn.fm/CNSP.
TinyGems published this content - they are a specialized communications platform focused on innovative small-cap and mid-cap companies, providing news distribution and corporate communications services through their parent organization IBN.
Readers can receive SMS alerts from TinyGems by texting 'Gems' to 888-902-4192 (U.S. Mobile Phones Only) or visit their website at https://www.TinyGems.com for more information.
Curated from InvestorBrandNetwork (IBN)
